REFERENCES
- McCormick et al. A Case of a Central Conducting Lymphatic Anomaly
Responsive to Sirolimus. Pediatrics . 2016;137(1):e20152694 -
April 01, 2016
- Lopez-Gutierrez JC, Tovar JA. Chylothorax and chylous ascites:
Management and pitfalls. Seminars in Pediatric Surgery .
2014;23(5):298-302.
- Tutor JD. Chylothorax in Infants and Children. Pediatrics .
2014;133(4):722-733.
- Soto-Martinez M, Massie J. Chylothorax: Diagnosis and Management in
Children. Paediatric Respiratory Reviews. 2009;10(4):199-207.
- Light RW. Chylothorax and pseudochylothorax. In: Pleural
Diseases , 6th ed. Philadelphia, PA:Wolters Kluwer Lippincott Williams
and Wilkins; 2013
- Beghetti M, La Scala G, Belli D, Bugmann P, Kalangos A, Le
Coultre C. Etiology and management of pediatric chylothorax. J
Pediatr . 2000;136(5):653–658 pmid:10802499
- Shah D, Sinn JK. Octreotide as therapeutic option for congenital
idiopathic chylothorax: a case series. Acta
Paediatr . 2012;101(4):e151–e155 pmid:22092874
- Roehr CC, Jung A, Proquitté H, et al. Somatostatin or octreotide as
treatment options for chylothorax in young children: a systematic
review. Intensive Care Med . 2006;32(5):650–657pmid:16532329
- Church JT, Antunez AG, Dean A, et al. Evidence-based management of
chylothorax in infants. Journal of Pediatric Surgery .
2017;52(6):907-912.
- Das A, Shah PS. Octreotide for the treatment of chylothorax in
neonates. Cochrane Database Syst Rev. 2010; (9):CD006388
pmid:20824848
- Wiegand S, Wichmann G, Dietz A. Treatment of Lymphatic Malformations
with the mTOR Inhibitor Sirolimus: A Systematic
Review. Lymphatic Research and Biology . 2018;16(4):330-339.
- Inoki K, Corradetti MN, Guan KL. Dysregulation of the TSC-mTOR pathway
in human disease. Nat Genet. 2005;37(1):19–24pmid:15624019
- Adams DM, Trenor CC, Hammill AM, et al. Efficacy and Safety of
Sirolimus in the Treatment of Complicated Vascular
Anomalies. Pediatrics. 2016;137(2).
- Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elleru R, et al.
Sirolimus for the treatment of complicated vascular anomalies in
children. Pediatr Blood Cancer 2011; 57:1018-24.
- McCormack FX, Inoue Y, Moss J, Singer LG, Strange C, Naka K, et al.
Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N
Engl J Med 2011;364:1596-1606.
- McCormick et al. A Case of a Central Conducting Lymphatic Anomaly
Responsive to Sirolimus. Pediatrics.
2016;137(1):e20152694. Pediatrics . 2016;137(4).
- Chen W, Adams D, Patel M, Gupta A, Dasgupta R. Generalized lymphatic
malformation with chylothorax: Long-term management of a highly morbid
condition in a pediatric patient. Journal of Pediatric Surgery .
2013;48(3).
- Ricci KW, Hammill AM, Mobberley-Schuman P, et al. Efficacy of systemic
sirolimus in the treatment of generalized lymphatic anomaly and
Gorham-Stout disease. Pediatric Blood & Cancer . 2019.
- Hodges MM, Crombleholme TM, Meyers M, et al. Massive fetal chylothorax
successfully treated with postnatal talc pleurodesis: A case report
and review of the literature. Journal of Pediatric Surgery Case
Reports . 2016;9:1-4.